Need professional-grade analysis? Visit stockanalysis.com
$844.48M
N/A
174
N/A
Anteris Technologies Global Corp (AVR) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at AUD8.20, down 3.53% from the previous close.
Over the past year, AVR has traded between a low of AUD4.68 and a high of AUD9.75. The stock has gained 45.9% over this period. It is currently 15.9% below its 52-week high.
Anteris Technologies Global Corp has a market capitalization of $844.48M.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Side-by-side comparison against top Healthcare peers.